文献速递肝病消化道肿瘤与早癌

综述:肝硬化患者体成分异常的预后意义

Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.
PubMed 文献 · Aliment Pharmacol Ther · 2020-07-03

该综述检索PubMed英文全文文献,排除CT体成分标记或界定不当的研究,总结肝硬化中肌肉减少症、皮下脂肪、内脏脂肪及脂肪组织放射密度等体成分异常的频率与临床意义,并指出进一步评估体成分异常可能有助于制定靶向治疗策略及改善肝移植优先排序。

要点

  • 肌肉减少症是影响肝硬化患者发病率和死亡率的明确因素。
  • 肝硬化女性低皮下脂肪与较高死亡风险相关,男性高内脏脂肪与较高肝细胞癌及肝移植后复发风险相关。
  • 脂肪组织放射密度增加与失代偿和死亡风险相关。

核心结论

  • 进一步评估体成分异常可能有助于制定靶向治疗策略并改善肝硬化患者结局。
  • 识别这些异常可能改善肝移植优先排序,因当前仅基于肝功能的方​​法可能导致风险误分类。

研究设计与样本

  • 综述:检索PubMed数据库,限定英文全文论文,排除使用不恰当标记或界定CT图像体成分的研究。

主要发现

  • 肌肉减少症是影响肝硬化发病率和死亡率的明确因素。
  • 肝硬化女性低皮下脂肪与较高死亡风险相关,男性高内脏脂肪与较高肝细胞癌及肝移植后复发风险相关。
  • 脂肪组织放射密度增加与失代偿和死亡风险相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent advances in evaluation of body composition show body mass index to be inadequate in differentiating between body compartments in cirrhosis. Given the limitations of body mass index, body composition evaluation using computed tomography has been increasingly used as a non-invasive clinical tool with prognostic value. Another factor influencing prognosis includes sex-specific differences in body composition that are seen in cirrhosis. AIM: To review current knowledge regarding the frequency and clinical implications of abnormal body composition features in cirrhosis. METHODS: We searched PubMed database and limited the literature search to full-text papers published in English. Studies using inappropriate landmarks or demarcation of body composition components on computed tomography images were eliminated. RESULTS: Sarcopenia is a well established factor affecting morbidity and mortality in cirrhosis. Other important body composition components that have been overlooked thus far include subcutaneous adipose tissue and visceral adipose tissue. Female patients with cirrhosis and low subcutaneous adiposity have a higher risk of mortality, whereas male patients with high visceral adiposity have a higher risk of hepatocellular carcinoma and recurrence following liver transplantation. Increased adipose tissue radiodensity has been associated with risk of decompensation and mortality. CONCLUSIONS: Further evaluation of body composition abnormalities may help with development of targeted therapeutic strategies and improve outcome in patients with cirrhosis. Moreover, recognition of these abnormalities could improve prioritisation for liver transplantation as our current method based solely on liver function might lead to risk misclassification.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ebadi M, Bhanji RA, Tandon P, et al. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment Pharmacol Ther. 2020. PMID: 32621329. doi:10.1111/apt.15927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。